ScholarLens Back to search
2000•Acta Scientiarum Naturalium Universitatis SunyatseniRequires access

Role of Octreotide in the Treatment of Chemotherapy-Induced and Radiotherapy Induced Diarrhoea

JavedIqbalFarooqi, RukhsanaJavedFarooqi

Open publisher page 0 citations

Abstract

Chemotherapy and Radiotherapy induced diarrhea is not an uncommon clinical problem. If not controlled in time, then weight-loss and other features of malnutrition are unavoidable. Therefore, management of such cases is of utmost importance. Appropriate therapy should be initiated in time to control the intestinal losses in time. A randomized clinical trial was conducted from Jan/1994 to Dec/1998 to find out the efficacy of octreotide versus loperamide in the treatment of Chemotherapy and Radioherapy - induced diarrhea. 125 patients were studied. 63 patients were given octreotide 100 μg, S/C,

About this research paper

What this paper is about

Chemotherapy and Radiotherapy induced diarrhea is not an uncommon clinical problem. If not controlled in time, then weight-loss and other features of malnutrition are unavoidable. Therefore, management of such cases is of utmost importance. Appropriate therapy should be initiated in time to control the intestinal losses in time. A randomized clinical trial was conducted from Jan/1994 to Dec/1998 to find out the efficacy of octreotide versus loperamide in the treatment of Chemotherapy and Radioherapy - induced diarrhea. 125 patients were studied. 63 patients were given octreotide 100 μg, S/C,

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Chemotherapy and Radiotherapy induced diarrhea is not an uncommon clinical problem. If not controlled in time, then weight-loss and other features of malnutrition are unavoidable. Therefore, management of such cases is of utmost importance. Appropriate therapy should be initiated in time to control the intestinal losses in time. A randomized clinical trial was conducted from Jan/1994 to Dec/1998 to find out the efficacy of octreotide versus loperamide in the treatment of Chemotherapy and Radioherapy - induced diarrhea. 125 patients were studied. 63 patients were given octreotide 100 μg, S/C,

Key concepts: Octreotide, Loperamide, Medicine, Diarrhea, Radiation therapy, Chemotherapy, Weight loss, Malnutrition

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Role of Octreotide in the Treatment of Chemotherapy-Induced and Radiotherapy Induced Diarrhoea — Research Paper | ScholarLens